Aliccia Bollig-fischer PhD

Aliccia Bollig-Fischer is a Technical Director at Helix Diagnostics, Waterford, Michigan, United States. The Bollig-Fischer laboratory applies state-of-the-art genomic methodologies, molecular biology, and in vivo approaches to tackle clinically relevant cancer research challenges, with a focus on studying how lifestyle factors, comorbidities, and systemic pathophysiology impact oncogene selection and tumorigenesis. Dr. Bollig-Fischer’s research efforts lead to the recent discovery of an obesity-induced nuclear factor promoting triple-negative breast cancer tumor incidence